Wouter W. de Herder

机构：Erasmus MC, Erasmus MC Cancer Institute, Erasmus University Rotterdam · ORCID：0000-0003-1463-5165

发表论文 660 篇 · 总被引 38952 次 · h-index 96

代表论文

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study (2024 · The Lancet · 被引 374)
Approach to the Patient: Insulinoma (2023 · The Journal of Clinical Endocrinology & Metabolism · 被引 87)
[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study. (2024 · Journal of Clinical Oncology · 被引 45)
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators (2023 · Endocrine Reviews · 被引 31)
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN (2024 · The Lancet Regional Health - Europe · 被引 28)
Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion (2023 · Frontiers in Endocrinology · 被引 23)